Canadian Entry To Practice Canadian Entry To Practice Medication Therapy Management 3

Question 1

Under Canadian pharmacy legislation, which action is within the expanded scope of practice for pharmacists in most provinces?

Accepted Answer

Prescribing for minor ailments and adapting prescriptions

Answer

Most Canadian provinces now allow pharmacists to prescribe for minor ailments and adapt existing prescriptions within their legislated scope of practice.

Question 2

What is a Drug Therapy Problem (DTP) in the context of pharmaceutical care?

Accepted Answer

Any undesirable event experienced by a patient that involves drug therapy and interferes with achieving treatment goals

Answer

A Drug Therapy Problem is any undesirable event involving drug therapy that prevents a patient from achieving their therapeutic goals and requires pharmacist intervention.

Question 3

A patient with atrial fibrillation is prescribed apixaban. What laboratory test does NOT require routine monitoring with this direct oral anticoagulant (DOAC)?

Accepted Answer

INR (International Normalized Ratio)

Answer

Unlike warfarin, DOACs such as apixaban do not require routine INR monitoring because they have predictable pharmacokinetics and fixed dosing.

Question 4

Which counseling strategy is most effective for improving patient adherence to long-term chronic disease medications?

Accepted Answer

Motivational interviewing combined with simplified dosing regimens

Answer

Motivational interviewing techniques combined with simplifying medication regimens (e.g., once-daily dosing) are evidence-based strategies that significantly improve long-term adherence.

Question 5

When providing a Medication Action Plan (MAP) as part of MTM, what is the primary audience for this document?

Accepted Answer

The patient, outlining self-management steps for their medications

Answer

The Medication Action Plan is a patient-facing document that outlines specific self-management actions the patient should take regarding their medications.